Efficacy and Safety of Mesotherapy With Minoxidil 0.5%/2ml for Androgenetic Alopecia in Female Patients
Status:
Unknown status
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
This study aims to investigate the effectiveness and safety of mesotherapy for the treatment
of female pattern alopecia.
- Sixty female subjects between 18 and 65 years diagnosed with female pattern hair loss
will undergo mesotherapy sessions weekly for ten weeks.
- One group will receive 0.5%/2ml minoxidil application and a control group will receive
application of placebo (saline 0.9%).
- Biopsy of the scalp, trichogram and trichoscopy (Fotofinder) will be performed before
and 08 weeks after treatment as a method objective evaluation of the response